Veracyte

VCYT NASDAQ
29.85
+0.34
+1.15%
After Hours: 29.85 0 0.00% 17:04 07/19 EDT
Open
29.51
Prev Close
29.51
High
29.93
Low
29.45
Volume
415.40K
Avg Vol (3M)
730.61K
52 Week High
30.25
52 Week Low
8.77
% Turnover
0.88%
Market Cap
1.40B
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Veracyte VCYT stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.
MORE >

Recently

Name
Price
%Change